Rosiglitazone Effects on Cognition for Adults in Later Life
Status:
Unknown status
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effects of the insulin-sensitizing medication
rosiglitazone on attention and memory skills in older adults with mild cognitive impairment
(MCI). The study also will examine the effects of this medication on brain structures that
support memory and other thinking abilities, and on biological markers associated with
inflammation, insulin resistance, and cardiovascular disease.